Boothbay Fund Management’s Eli Lilly LLY Stock Holding History

Boothbay Fund Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$537K	–	2296
2025 Q4	$537K	Buy	+500	New	+$478K	0.01%	1095
2025 Q2	–	Sell	-48,100	Closed	-$39.7M	–	1645
2025 Q1	$39.7M	Buy	+48,100	New	+$40M	1.05%	5
2024 Q3	–	Sell	-3,200	Closed	-$2.9M	–	1795
2024 Q2	$2.9M	Buy	+3,200	New	+$2.56M	0.07%	380
2024 Q1	–	Sell	-16,300	Closed	-$9.5M	–	1774
2023 Q4	$9.5M	Buy	+16,300	New	+$9.51M	0.24%	68
2022 Q4	–	Sell	-1,600	Closed	-$517K	–	2234
2022 Q3	$517K	Buy	1,600 +200	+14%	+$63.4K	0.01%	1211
2022 Q2	$454K	Sell	1,400 -2,200	-61%	-$660K	0.01%	1227
2022 Q1	$1.03M	Buy	+3,600	New	+$926K	0.02%	877
2019 Q2	–	Sell	-41	Closed	-$532K	–	820
2019 Q1	$532K	Sell	41 -583	-93%	-$70.9K	0.05%	368
2018 Q4	$7.22M	Buy	624 +246	+65%	+$27.5K	1.05%	16
2018 Q3	$4.06M	Hold	378	–	–	0.4%	53
2018 Q2	$3.23M	Hold	378	–	–	0.28%	68
2018 Q1	$2.92M	Buy	+378	New	+$30.4K	0.35%	71

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Boothbay Fund Management's LLY Position: Q1 2026 in Review

Boothbay Fund Management reduced its Eli Lilly (LLY) stake by 62% in Q1 2026, selling an estimated $4.27M and leaving 2,529 shares worth $2.33M. The position accounts for 0.03% of the portfolio, ranked #556.

Boothbay Fund Management first reported a position in LLY in Q3 2015 and has held it in 21 quarters since. The position peaked at $14.5M in Q1 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Boothbay Fund Management held 2,529 shares of Eli Lilly worth $2.33M as of Q1 2026.
Boothbay Fund Management sold 4,214 Eli Lilly shares in Q1 2026, an estimated $4.27M.
Eli Lilly made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #556 holding.
Boothbay Fund Management first reported a position in Eli Lilly in Q3 2015 and has held it in 21 quarters since.
Boothbay Fund Management's Eli Lilly position peaked at $14.5M in Q1 2023.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.